Changes in demographics, clinical practices and long-term outcomes of patients with ST segment-elevation myocardial infarction who underwent coronary revascularisation in the past two decades: cohort study.
Yasuaki TakejiHiroki ShiomiTakeshi MorimotoYusuke YoshikawaRyoji TaniguchiYukiko Mutsumura-NakanoKo YamamotoKyohei YamajiJunichi TazakiEri Toda KatoHirotoshi WatanabeErika YamamotoYugo YamashitaMasayuki FukiSatoru SuwaMoriaki InokoTeruki TakedaManabu ShirotaniNatsuhiko EharaKatsuhisa IshiiTsukasa InadaToshihiro TamuraTomoya OnoderaEiji ShinodaTakashi YamamotoHiroki WatanabeHidenori YakuKenji NakatsumaHiroki SakamotoKenji AndoYoshiharu SogaYutaka FurukawaYukihito SatoYoshihisa NakagawaKazushige KadotaTatsuhiko KomiyaKenji MinatoyaTakeshi Kimuranull nullPublished in: BMJ open (2021)
We could not demonstrate improvement in 3-year mortality risk from Wave-1 to Wave-2, but we found reduction in mortality risk beyond 30 days. We also found risk reduction for definite stent thrombosis and any coronary revascularisation, but an increase in the risk of major bleeding from Wave-1 to Wave-2.